← All organizations

Shanghai Miracogen Inc.

For profit

Also known as: Shanghai Miracogen Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2010s

Jun 1, 2013
Shanghai Miracogen Inc.— Founded

Drugs by trial phase (14 distinct, 25 trials)

Phase 3 (11 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

mrg001

Indications

Studied for

Neoplasms

Recent trials (25)

NCT07138846Lead sponsorPhase 3Jan 31, 2026
NCT07066657Lead sponsorPhase 1/Phase 2Jul 25, 2025
NCT06976190Lead sponsorPhase 3May 31, 2025
NCT07093970Lead sponsorPhase 1/Phase 2Jul 24, 2024
NCT05754853Lead sponsorPhase 3Apr 6, 2023
NCT05751512Lead sponsorPhase 3Mar 31, 2023
NCT05338957Lead sponsorPhase 1/Phase 2Aug 5, 2022
NCT05688605Lead sponsorPhase 1/Phase 2Jun 30, 2022
NCT05263869Lead sponsorPhase 2Mar 23, 2022
NCT05141747Lead sponsorPhase 2Dec 31, 2021
NCT05141786Lead sponsorPhase 2Dec 31, 2021
NCT05126719Lead sponsorPhase 2Aug 4, 2021
NCT04843709Lead sponsorPhase 1/Phase 2Jul 26, 2021
NCT04924699Lead sponsorPhase 2Jun 30, 2021
NCT04837508Lead sponsorPhase 2Jun 7, 2021

Details

Founded: Shanghai, CN Jun 1, 2013
Last known activity: Jan 31, 2026